Last update 21 Nov 2024

Tractinostat/Valganciclovir

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
DNA-directed DNA polymerase x HDAC1 x HDAC2 x HDAC3
Mechanism
DNA-directed DNA polymerase inhibitors, HDAC1 inhibitors(Histone deacetylase 1 inhibitors), HDAC2 inhibitors(Histone deacetylase 2 inhibitors)
+ [1]
Therapeutic Areas
Infectious Diseases
Active Indication
Epstein-Barr Virus Infections
Inactive Indication
Lymphoproliferative Disorders
Originator Organization
Viracta Therapeutics, Inc.Viracta Therapeutics, Inc.
Active Organization
Shenzhen Salubris Pharmaceuticals Co., Ltd.Shenzhen Salubris Pharmaceuticals Co., Ltd.Viracta Therapeutics, Inc.Viracta Therapeutics, Inc.
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC20H19FN6O2
InChIKeyQRGHOAATPOLDPF-VQFNDLOPSA-N
CAS Registry1256448-47-1
View All Structures (2)

Related

100 Clinical Results associated with Tractinostat/Valganciclovir
Login to view more data
100 Translational Medicine associated with Tractinostat/Valganciclovir
Login to view more data
100 Patents (Medical) associated with Tractinostat/Valganciclovir
Login to view more data
100 Deals associated with Tractinostat/Valganciclovir
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Epstein-Barr Virus InfectionsPhase 2-
Viracta Therapeutics, Inc.Viracta Therapeutics, Inc.
-
Epstein-Barr Virus InfectionsPhase 2-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Shenzhen Salubris Pharmaceuticals Co., Ltd.
-
Lymphoproliferative DisordersPhase 1
BR
Viracta Therapeutics, Inc.Viracta Therapeutics, Inc.
29 Mar 2018
Lymphoproliferative DisordersPhase 1
US
Viracta Therapeutics, Inc.Viracta Therapeutics, Inc.
29 Mar 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free